These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 31773463

  • 21. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
    Okomo-Adhiambo M, Nguyen HT, Sleeman K, Sheu TG, Deyde VM, Garten RJ, Xu X, Shaw MW, Klimov AI, Gubareva LV.
    Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
    [Abstract] [Full Text] [Related]

  • 22. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
    Neri-Bazán RM, García-Machorro J, Méndez-Luna D, Tolentino-López LE, Martínez-Ramos F, Padilla-Martínez II, Aguilar-Faisal L, Soriano-Ursúa MA, Trujillo-Ferrara JG, Fragoso-Vázquez MJ, Barrón BL, Correa-Basurto J.
    Eur J Med Chem; 2017 Mar 10; 128():154-167. PubMed ID: 28182988
    [Abstract] [Full Text] [Related]

  • 23. [Molecular genetic studies of the susceptibility of epidemic influenza A(H1N1) virus strains isolated in the 2006-2009 seasons in Russia to oseltamivir (Tamiflu)].
    Beliakova NV, Al'khovskiĭ SV, Shevchenko ES, Prilipov AG, Abramov DD, Kolobukhina LV, Merkulova LN, Trushakova SV, Burtseva EI.
    Vopr Virusol; 2010 Mar 10; 55(5):10-3. PubMed ID: 21260988
    [Abstract] [Full Text] [Related]

  • 24. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
    Cho HG, Choi JH, Lee HK, Mun SK, Lee JB, Jho EH, Kang C, Lim YH.
    Arch Virol; 2013 Nov 10; 158(11):2365-70. PubMed ID: 23690054
    [Abstract] [Full Text] [Related]

  • 25. Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus.
    Pokorná J, Pachl P, Karlukova E, Hejdánek J, Řezáčová P, Machara A, Hudlický J, Konvalinka J, Kožíšek M.
    Viruses; 2018 Jun 21; 10(7):. PubMed ID: 29933553
    [Abstract] [Full Text] [Related]

  • 26. Molecular mechanism of the enhanced viral fitness contributed by secondary mutations in the hemagglutinin protein of oseltamivir resistant H1N1 influenza viruses: modeling studies of antibody and receptor binding.
    Behera AK, Basu S, Cherian SS.
    Gene; 2015 Feb 15; 557(1):19-27. PubMed ID: 25479009
    [Abstract] [Full Text] [Related]

  • 27. Global emergence of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses with I223V and S247N mutations: implications for antiviral resistance monitoring.
    Leung RC, Ip JD, Chen LL, Chan WM, To KK.
    Lancet Microbe; 2024 Jul 15; 5(7):627-628. PubMed ID: 38493791
    [No Abstract] [Full Text] [Related]

  • 28. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.
    Yen HL, Ilyushina NA, Salomon R, Hoffmann E, Webster RG, Govorkova EA.
    J Virol; 2007 Nov 15; 81(22):12418-26. PubMed ID: 17855542
    [Abstract] [Full Text] [Related]

  • 29. Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report.
    Harada N, Shibata W, Koh H, Takashita E, Fujisaki S, Okamura H, Nanno S, Yamada K, Nakamae H, Hino M, Kakeya H.
    BMC Infect Dis; 2020 Jul 06; 20(1):478. PubMed ID: 32631240
    [Abstract] [Full Text] [Related]

  • 30. A conformational restriction in the influenza A virus neuraminidase binding site by R152 results in a combinational effect of I222T and H274Y on oseltamivir resistance.
    Huang L, Cao Y, Zhou J, Qin K, Zhu W, Zhu Y, Yang L, Wang D, Wei H, Shu Y.
    Antimicrob Agents Chemother; 2014 Jul 06; 58(3):1639-45. PubMed ID: 24366752
    [Abstract] [Full Text] [Related]

  • 31. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ, Du QS, Huang RB, Zhang DW, Chou KC.
    Biochem Biophys Res Commun; 2009 Aug 28; 386(3):432-6. PubMed ID: 19523442
    [Abstract] [Full Text] [Related]

  • 32. In Vitro and In Vivo Characterization of Novel Neuraminidase Substitutions in Influenza A(H1N1)pdm09 Virus Identified Using Laninamivir-Mediated In Vitro Selection.
    Lloren KKS, Kwon JJ, Choi WS, Jeong JH, Ahn SJ, Choi YK, Baek YH, Song MS.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30602610
    [Abstract] [Full Text] [Related]

  • 33. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
    Yang JR, Huang YP, Chang FY, Hsu LC, Huang HY, Pan YT, Lin YC, Wu HS, Liu MT.
    J Med Virol; 2013 Mar 15; 85(3):379-87. PubMed ID: 23280715
    [Abstract] [Full Text] [Related]

  • 34. Computational studies of H5N1 influenza virus resistance to oseltamivir.
    Wang NX, Zheng JJ.
    Protein Sci; 2009 Apr 15; 18(4):707-15. PubMed ID: 19309695
    [Abstract] [Full Text] [Related]

  • 35. Neuraminidase amino acids 149 and 347 determine the infectivity and oseltamivir sensitivity of pandemic influenza A/H1N1 (2009) and avian influenza A/H5N1.
    Yongkiettrakul S, Nivitchanyong T, Pannengpetch S, Wanitchang A, Jongkaewwattana A, Srimanote P.
    Virus Res; 2013 Aug 15; 175(2):128-33. PubMed ID: 23639424
    [Abstract] [Full Text] [Related]

  • 36. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.
    Bloom JD, Gong LI, Baltimore D.
    Science; 2010 Jun 04; 328(5983):1272-5. PubMed ID: 20522774
    [Abstract] [Full Text] [Related]

  • 37. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
    Duwe SC, Wedde M, Birkner P, Schweiger B.
    Antiviral Res; 2011 Jan 04; 89(1):115-8. PubMed ID: 21070812
    [Abstract] [Full Text] [Related]

  • 38. Genetic sequencing of influenza A (H1N1) pdm09 isolates from South India, collected between 2011 and 2015 to detect mutations affecting virulence and resistance to oseltamivir.
    Nandhini P, Sistla S.
    Indian J Med Microbiol; 2020 Jan 04; 38(3 & 4):324-337. PubMed ID: 33154243
    [Abstract] [Full Text] [Related]

  • 39. Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme.
    Bantia S, Upshaw R, Babu YS.
    Antiviral Res; 2011 Sep 04; 91(3):288-91. PubMed ID: 21722670
    [Abstract] [Full Text] [Related]

  • 40. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.
    Dixit R, Khandaker G, Ilgoutz S, Rashid H, Booy R.
    Infect Disord Drug Targets; 2013 Feb 04; 13(1):34-45. PubMed ID: 23675925
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.